Donald P. Tashkin

38.9k total citations · 2 hit papers
525 papers, 24.5k citations indexed

About

Donald P. Tashkin is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Donald P. Tashkin has authored 525 papers receiving a total of 24.5k indexed citations (citations by other indexed papers that have themselves been cited), including 365 papers in Pulmonary and Respiratory Medicine, 222 papers in Physiology and 75 papers in Pathology and Forensic Medicine. Recurrent topics in Donald P. Tashkin's work include Chronic Obstructive Pulmonary Disease (COPD) Research (229 papers), Asthma and respiratory diseases (168 papers) and Respiratory Support and Mechanisms (93 papers). Donald P. Tashkin is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (229 papers), Asthma and respiratory diseases (168 papers) and Respiratory Support and Mechanisms (93 papers). Donald P. Tashkin collaborates with scholars based in United States, United Kingdom and Canada. Donald P. Tashkin's co-authors include Steven Kesten, Michael D. Roth, Bartolomé R. Celli, Marc Decramer, D Burkhart, Shailendra Menjoge, Stephen Senn, Michael S. Simmons, Henry Gong and Philip J. Clements and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Donald P. Tashkin

512 papers receiving 23.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease

2008 1.6k citations Donald P. Tashkin, Bartolomé R. Celli et al. profile →
Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function

2016 418 citations R. Graham Barr, Stephanie A. Christenson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Donald P. Tashkin United States	85	15.0k	9.6k	3.9k	3.0k	2.6k	525	24.5k
Richard Casaburi United States	72	31.0k 2.1×	15.4k 1.6×	843 0.2×	872 0.3×	2.0k 0.8×	312	43.4k
Gary C. Curhan United States	107	11.1k 0.7×	3.5k 0.4×	1.2k 0.3×	5.2k 1.8×	4.9k 1.9×	404	41.8k
Stephen I. Rennard United States	93	20.5k 1.4×	12.3k 1.3×	738 0.2×	1.0k 0.3×	2.5k 1.0×	594	35.7k
John Deanfield United Kingdom	113	9.8k 0.7×	8.3k 0.9×	2.1k 0.5×	2.3k 0.8×	10.5k 4.0×	545	58.7k
Eberhard Ritz Germany	97	6.9k 0.5×	4.2k 0.4×	1.8k 0.5×	4.9k 1.7×	2.3k 0.9×	934	44.8k
Mark A. Creager United States	99	11.4k 0.8×	8.1k 0.8×	1.6k 0.4×	1.6k 0.5×	5.8k 2.2×	352	48.5k
Gerardo Heiss United States	100	5.4k 0.4×	4.4k 0.5×	863 0.2×	2.2k 0.7×	6.0k 2.3×	533	40.8k
Coen D.A. Stehouwer Netherlands	119	4.2k 0.3×	12.4k 1.3×	1.8k 0.5×	2.8k 0.9×	9.9k 3.8×	1.1k	57.4k
Robert W. Schrier United States	94	11.3k 0.8×	3.7k 0.4×	1.5k 0.4×	2.7k 0.9×	4.0k 1.5×	568	38.4k
Kamyar Kalantar‐Zadeh United States	121	6.1k 0.4×	11.4k 1.2×	725 0.2×	2.2k 0.7×	3.6k 1.4×	916	52.3k

Countries citing papers authored by Donald P. Tashkin

Since Specialization

Citations

This map shows the geographic impact of Donald P. Tashkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald P. Tashkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald P. Tashkin more than expected).

Fields of papers citing papers by Donald P. Tashkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald P. Tashkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald P. Tashkin. The network helps show where Donald P. Tashkin may publish in the future.

Co-authorship network of co-authors of Donald P. Tashkin

This figure shows the co-authorship network connecting the top 25 collaborators of Donald P. Tashkin. A scholar is included among the top collaborators of Donald P. Tashkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald P. Tashkin. Donald P. Tashkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tashkin, Donald P., et al.. (2024). Prevalence and Management of Chronic Obstructive Pulmonary Disease in the Gulf Countries with a Focus on Inhaled Pharmacotherapy. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 37(4). 189–201. 5 indexed citations

Fang, Fang, Beate Ritz, Jianyu Rao, et al.. (2024). Association between ambient exposure to PM_2.5 and upper aerodigestive tract cancer in Los Angeles. International Journal of Cancer. 154(9). 1579–1586. 6 indexed citations

Meyers, Travis J., P. H. Kevin Chang, Hal Morgenstern, et al.. (2017). Case‐control study of cumulative cigarette tar exposure and lung and upper aerodigestive tract cancers. International Journal of Cancer. 140(9). 2040–2050. 14 indexed citations

Kafaja, Suzanne, Philip J. Clements, Holly Wilhalme, et al.. (2017). Reliability and Minimal Clinically Important Differences of FVC. Results from the Scleroderma Lung Studies (SLS-I and SLS-II). American Journal of Respiratory and Critical Care Medicine. 197(5). 644–652. 86 indexed citations

Gong, Henry, et al.. (2015). Hypoxia-Altitude Simulation Test. American Review of Respiratory Disease. 1 indexed citations

Paulin, Laura M., Gregory B. Diette, Paul D. Blanc, et al.. (2015). Occupational Exposures Are Associated with Worse Morbidity in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 191(5). 557–565. 74 indexed citations

Park, Hye Yun, Andrew Churg, James R. Wright, et al.. (2013). Club Cell Protein 16 and Disease Progression in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 188(12). 1413–1419. 98 indexed citations

Drummond, Michael, Nadia N. Hansel, John E. Connett, et al.. (2012). Spirometric Predictors of Lung Function Decline and Mortality in Early Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 185(12). 1301–1306. 76 indexed citations

Hanania, Nicola A., Amir Sharafkhaneh, Bartolomé R. Celli, et al.. (2011). Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial. Respiratory Research. 12(1). 6–6. 66 indexed citations

10.

Mao, Jenny T., Michael D. Roth, Michael C. Fishbein, et al.. (2011). Lung Cancer Chemoprevention with Celecoxib in Former Smokers. Cancer Prevention Research. 4(7). 984–993. 65 indexed citations

11.

Sin, Don D., Bruce E. Miller, Annelyse Duvoix, et al.. (2011). Serum PARC/CCL-18 Concentrations and Health Outcomes in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 183(9). 1187–1192. 84 indexed citations

12.

Celli, Bartolomé R., Marc Decramer, Steven Kesten, et al.. (2009). Mortality in the 4-Year Trial of Tiotropium (UPLIFT) in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 180(10). 948–955. 206 indexed citations

13.

Harber, Philip, Donald P. Tashkin, & Eva Hnizdo. (2008). Effects of Misclassification of Fume Exposure. American Journal of Respiratory and Critical Care Medicine. 177(10). 1172–1172. 2 indexed citations

14.

Strange, Charlie, Marcy B. Bolster, Michael D. Roth, et al.. (2007). Bronchoalveolar Lavage and Response to Cyclophosphamide in Scleroderma Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine. 177(1). 91–98. 92 indexed citations

15.

Harber, Philip, Donald P. Tashkin, Michael Simmons, et al.. (2007). Effect of Occupational Exposures on Decline of Lung Function in Early Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 176(10). 994–1000. 67 indexed citations

16.

Littner, Michael R., Jonathan Ilowite, Donald P. Tashkin, et al.. (2000). Long-Acting Bronchodilation with Once-Daily Dosing of Tiotropium (Spiriva) in Stable Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 161(4). 1136–1142. 162 indexed citations

17.

Crapo, Robert O., et al.. (1999). Arterial Blood Gas Reference Values for Sea Level and an Altitude of 1,400 Meters. American Journal of Respiratory and Critical Care Medicine. 160(5). 1525–1531. 146 indexed citations

18.

Roth, Michael D., et al.. (1998). Airway Inflammation in Young Marijuana and Tobacco Smokers. American Journal of Respiratory and Critical Care Medicine. 157(3). 928–937. 168 indexed citations

19.

Wise, Robert A., Paul Enright, John E. Connett, et al.. (1998). Effect of Weight Gain on Pulmonary Function after Smoking Cessation in the Lung Health Study. American Journal of Respiratory and Critical Care Medicine. 157(3). 866–872. 75 indexed citations

20.

Baldwin, Gayle Cocita, et al.. (1997). Marijuana and Cocaine Impair Alveolar Macrophage Function and Cytokine Production. American Journal of Respiratory and Critical Care Medicine. 156(5). 1606–1613. 184 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact